Results 91 to 100 of about 7,222 (160)

Evaluation of immunological response Against SARS-CoV-2 in risk groups vaccinated with CoronaVac

Neste trabalho, tivemos como objetivo avaliar a resposta de grupos vulneráveis à COVID-19, como idosos e pacientes com Imunodeficiência Comum Variável (ICV), vacinados com CoronaVac.
Medeiros, Giuliana Xavier de
core   +1 more source

CoronaVac efficacy data from Turkey – Authors' reply

The Lancet, 2021
Tanriover, Mine Durusu, Doğanay, Hamdi Levent, Unal, Serhat, Akova, Murat   +3 more
openaire   +3 more sources

SARS‐CoV‐2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two‐dose CoronaVac vaccine regimen [PDF]

Journal of Medical Virology, 2021
Ali Umit, Keskin, Sibel, Bolukcu, Pinar, Ciragil, Aynur Eren, Topkaya   +3 more
openaire   +2 more sources

Safety, immunogenicity, and long COVID outcomes following inactivated COVID-19 vaccine boosters in elderly Chinese: a prospective cohort study. [PDF]

Front Immunol
Dai R, Hua Q, Liu X, Ma L, Bao R, Lei H, Yu P, Liao Y, Yang J, Han S, Jiang J, Zhang H.   +11 more
europepmc   +1 more source

Heterologous RBMRNA-405 mRNA booster enhances humoral immunity post-inactivated COVID-19 vaccination: a randomized clinical trial in adults and older through 12 months. [PDF]

Sci Rep
Yong X, He J, Zhang C, Wang Y, Ou Y, Zhang B.   +5 more
europepmc   +1 more source

Long-Term Durability and Dynamics of Anti-S-RBD IgG Response in Healthcare Workers: A Comparative Analysis of Homologous and Heterologous SARS-CoV-2 Vaccination Schedules in a 1-Year Serial Cross-Sectional Study. [PDF]

Med Sci Monit
Demirel Ç, Kibar F, Dağlıoğlu G, Çetiner S, Candevir A, İnal AS, Yücel Karakaya SP, Görüroğlu Öztürk Ö, Gümüş HH, İnal TC.   +9 more
europepmc   +1 more source

Comparative effectiveness of COVID-19 vaccines among health students, focusing on methodological concerns. [PDF]

Antimicrob Steward Healthc Epidemiol
Cakir B, Sertcelik A, Karadogan E, Uzar H, Temizer M, Kara SA, Ozden ME, Buzgan B, Ozyurek D, Alp A, Pinar A, Ayhan Baser D, Aksoy H, Fidanci I, Calik Basaran N, Ozyavuz Alp S, Arslan V, Sener B.   +17 more
europepmc   +1 more source

Four doses of coronavirus disease 2019 vaccination for patients with inborn errors of immunity compared to 3 doses for healthy individuals. [PDF]

J Allergy Clin Immunol Glob
Chan JCH, Cheng SMS, Leung D, Wang X, Wang M, Cheuk YC, Ho C, Tsang LCH, Kwan TC, Lee AMT, Li WY, Lam JHY, Zhang K, Tam IYS, Chan SM, Chan KW, Peiris M, Tu W, Lau YL, Rosa Duque JS.   +19 more
europepmc   +1 more source

A predictive model for rapid assessment of protective efficacy against emerging SARS-CoV-2 variants. [PDF]

Infect Dis Model
Jin L, Jia S, Shao C, Shen R, Jin P, Li J.   +5 more
europepmc   +1 more source

Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2. [PDF]

Vaccines (Basel)
Tangsathapornpong A, Nanthapisal S, Fukpho W, Bunjoungmanee P, Neamkul Y, Pontan K, Boonyarangkul A, Wanpen S, Thongphubeth K, Tharabenjasin P, Jaru-Ampornpan P.   +10 more
europepmc   +1 more source